The FDA report on counterfeit drugs has only been out for seven months and already at least one group has stepped forward to show that a “track and trace” method of tracking drugs is feasible.
On Sept. 28, a group managed by Accenture released its first report on utilizing EPC and RFID technologies across the pharmaceutical supply chain. The group was first formed back in February, days after the FDA report was released, and includes pharmaceutical manufacturers, distributors and retailers.
Findings based on shipping, tracking and tracing nearly 13,500 packages of pharmaceuticals over an eight week period, showed that EPC/RFID can help satisfy regulatory and retailer requirements, increase product security and consumer safety, enhance order accuracy and labor productivity, and increase the efficiency and speed of recalls and returns, according to Accenture. These tests, however, applied to the supply chain only and did not involve consumer-level testing.
There are 861 words in the rest of this article …
Library Access Required
Library subscribers have access to the full archives of more than 10,000 original news items and feature articles published by AVISIAN’s suite of ID technology publications (ContactlessNews.com, CR80News.com, DigitalIDNews.com, FIPS201.com, NFCNews.com, RFIDNews.org, SecureIDNews.com, and ThirdFactor.com).
For just $49, you receive unlimited password-protected access to content on all of AVISIAN’s sites for an entire year. Your subscription helps fund the continued creation of independent, insightful content. Find out more.
Sign in as a Subscriber
If you are already a subscriber, you may sign in now. Enter your Email Address and Password and click Sign In.
If you have forgotten your password, enter just your Email Address, and click Send Password.
